Chi-Med to Raise $301 Million in US Secondary Offering

Oct 25, 2017

Life Science

ONCLIVE: Novel Alkylating Agent Defies Mechanisms of Resistance in GBM Tumors

Oct 25, 2017

Life Science

Resverlogix Announces Right of First Refusal Agreement with Hepalink USA Inc.

Oct 24, 2017

Life Science

Transgene Reports Positive Data on its Tasly-Partnered HBV Therapy

Oct 23, 2017

Life Science

Future Farm Builds Vertical Supply Chain with Acquisition — CFN Media

Oct 20, 2017

Life Science

Hong Kong’s Nan Fung Leads $45 Million Round for US Hearing Device Maker

Oct 20, 2017

Life Science

GIMDx/Improve Medical Gain China Rights to PD-L1 Quantifying Assay

Oct 19, 2017

Life Science

FibroGen Says CFDA Accepts Novel Anemia NDA for Review

Oct 19, 2017

Life Science

More FDI moves in the pipeline

Oct 19, 2017

Financial Service, Life Science, Technology

WuXi AppTec to Acquire Texas-Based Global Clinical Trial CRO

Oct 18, 2017

Life Science

Shanghai Pharma says bid for U.S. Cardinal Health’s China business

Oct 18, 2017

Life Science

AstraZeneca: FDA grants Imfinzi priority review

Oct 17, 2017

Life Science

Chi-Med/AstraZeneca Drug Shows Efficacy Against Lung Cancer

Oct 17, 2017

Life Science

Shenzhen Hepalink Invests $69 Million in Canada’s Resverlogix

Oct 16, 2017

Life Science

Innovent Licenses Use of Harbour Biomed’s Biologic Drug Discovery Platform

Oct 13, 2017

Life Science

CASI Pharma Raises $23 Million in Private Placement

Oct 13, 2017

Life Science

IIROC Trade Resumption – RVX

Oct 13, 2017

Life Science

Resverlogix Announces $87 Million Private Placement with Shenzhen Hepalink

Oct 13, 2017

Life Science